We have developed a kind of novel fused-ring small molecular acceptor, whose planar conformation can be locked by intramolecular noncovalent interaction. The formation of planar supramolecular fused-ring structure by conformation locking can effectively broaden its absorption spectrum, enhance the electron mobility, and reduce the nonradiative energy loss. Polymer solar cells (PSCs) based on this acceptor afforded a power conversion efficiency (PCE) of 9.6%. In contrast, PSCs based on similar acceptor, which cannot form a flat conformation, only gave a PCE of 2.3%. Such design strategy, which can make the synthesis of small molecular acceptor much easier, will be promising in developing a new acceptor for high efficiency polymer solar cells.
Three
novel non-fullerene small molecular acceptors ITOIC, ITOIC-F, and ITOIC-2F were designed and
synthesized with easy chemistry. The concept of supramolecular chemistry
was successfully used in the molecular design, which includes noncovalently
conformational locking (via intrasupramolecular interaction) to enhance
the planarity of backbone and electrostatic interaction (intersupramolecular
interaction) to enhance the π–π stacking of terminal
groups. Fluorination can further strengthen the intersupramolecular
electrostatic interaction of terminal groups. As expected, the designed
acceptors exhibited excellent device performance when blended with
polymer donor PBDB-T. In comparison with the parent acceptor molecule
DC-IDT2T reported in the literature with a power conversion efficiency
(PCE) of 3.93%, ITOIC with a planar structure exhibited
a PCE of 8.87% and ITOIC-2F with a planar structure and
enhanced electrostatic interaction showed a quite impressive PCE of
12.17%. Our result demonstrates the importance of comprehensive design
in the development of high-performance non-fullerene small molecular
acceptors.
The uranyl dication shows photocatalytic activity towards C(sp )-H bonds of aliphatic compounds, but not towards those of alkylbenzenes or cyclic ketones. Theoretical insights into the corresponding mechanisms are still limited. Multi-configurational ab initio calculations including relativistic effects reveal the inherent electron-transfer mechanism for the uranyl catalyzed C-H fluorination under blue light. Along the reaction path of the triplet state it was found that the hydrogen atom abstraction triggered by the electron-rich oxygen of the uranyl moiety is the rate-limiting step. The subsequent steps, that is, N-F and O-H bond breakage in a manner of concerted asynchronicity, generation of the targeted fluorinated product, and recovery of the photocatalyst are nearly barrierless. Moreover the single electron transfer between the reactive substrates plays a fundamental role during the whole photocatalytic cycle.
Development of versatile, chemically tunable photocages for photoactivated chemotherapy (PACT) represents an excellent opportunity to address the technical drawbacks of conventional photodynamic therapy (PDT) whose oxygen-dependent nature renders it inadequate in certain therapy contexts such as hypoxic tumors. As an alternative to PDT, oxygen free mechanisms to generate cytotoxic reactive oxygen species (ROS) by visible light cleavable photocages are in demand. Here, we report the detailed mechanisms by which the small molecule blebbistatin acts as a one-photon blue light-gated or twophoton near-infrared light-gated photocage to directly release a hydroxyl radical (•OH) in the absence of oxygen. By using femtosecond transient absorption spectroscopy and chemoselective ROS fluorescent probes, we analyze the dynamics and fate of blebbistatin during photolysis under blue light. Waterdependent photochemistry reveals a critical process of water-assisted protonation and excited state intramolecular proton transfer (ESIPT) that drives the formation of short-lived intermediates, which surprisingly culminates in the release of •OH but not superoxide or singlet oxygen from blebbistatin. CASPT2//CASSCF calculations confirm that hydrogen bonding between water and blebbistatin underpins this process. We further determine that blue light enables blebbistatin to induce mitochondria-dependent apoptosis, an attribute conducive to PACT development. Our work demonstrates blebbistatin as a controllable photocage for •OH generation and provides insight into the potential development of novel PACT agents.
Photo-induced cleavage of C(sp2)–Cl bonds is an appealing synthetic tool in organic synthesis, but usually requires the use of high UV light, photocatalysts and/or photosensitizers. Herein is described a direct...
A luminescent tungsten(vi) complex catalyses a broad spectrum of light-driven organic transformation reactions with high product yields and good functional group tolerance.
The search for a highly active nitrido complex that can transfer its nitrogen atom to inert organic molecules remains a challenge to chemists. In this regard, the use of solar energy to generate a reactive nitrido species is an appealing strategy to solve this problem. Here we report the design of a strongly luminescent osmium(VI) nitrido compound, [OsVI(N)(NO2-L)(CN)3]− (NO2-OsN) with emission quantum yield (Φ) and life time (τ) of 3.0% and 0.48 μs, respectively in dichloromethane solution. Upon irradiation with visible light, this complex readily activates the aliphatic C-H bonds of various hydrocarbons, including alkanes. The excited state of NO2-OsN can undergo ring-nitrogenation of arenes, including benzene. Photophysical and computational studies suggest that the excited state of NO2-OsN arises from O^N ligand to Os ≡ N charge transfer transitions, and as a result it possesses [Os = N•] nitridyl character and is highly electrophilic.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.